Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.

BMC Endocr Disord · 2026 · PMC13224483 · PMID 41998571

Europe PMC DOI

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

did not reach statistical significancep = 0.290not close (p > 0.1)

Although reductions in nocturnal (03:00 AM) and fasting blood glucose levels tended to be greater in patients with baseline HbA1c ≥ 9%, these differences did not reach statistical significance ( p = 0.290 and p = 0.104, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.